Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
General Discussion
In reply to the discussion: Healthline.com: Should Multiple Sclerosis Drugs Cost $62,000 a Year? [View all]kelliekat44
(7,759 posts)60. There are ways to protect against that...there must be. One way is to keep Sen. Dogpatch from being
elected!!
Edit history
Please sign in to view edit histories.
Recommendations
0 members have recommended this reply (displayed in chronological order):
73 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
RecommendedHighlight replies with 5 or more recommendations
10 to 1 that the research that went into these drugs was mostly paid for by Federal grants
kelliekat44
Mar 2014
#5
There are ways to protect against that...there must be. One way is to keep Sen. Dogpatch from being
kelliekat44
Mar 2014
#60
Single payer would not solve this problem. The same issue affects Medicare and countries
pnwmom
Mar 2014
#42
Yes, i agree there was fear of fighting too hard to get something that the right was against.
bravenak
Mar 2014
#43
You said it!! I worked in that system so I really know what goes out of public view. nt
kelliekat44
Mar 2014
#59
The United States and New Zealand are the only two countries where direct to consumer advertising of
smokey nj
Mar 2014
#61
Time was that medicine was a vocation, its mission was to serve & to save lives.
reformist2
Mar 2014
#30
No, they should not. But people should be aware that under the ACA, an insurer may NOT
pnwmom
Mar 2014
#40
I used to work in the biotechnology/pharmaceutical industry, and just FYI
TrollBuster9090
Mar 2014
#54
Betaseron is available only to 1 in 8 UK MS patients under the NHS ("Postcode lottery")
Nye Bevan
Mar 2014
#64